1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. GENMAB - ADR
28.04 -0.04 (-0.14%)
1.1M
XNAS Volume

XNAS 18 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

US Politician trade disclosures for Genmab - ADR from January 14, 2025 to September 19, 2025

Representative Josh Gottheimer discloses a trade of $1K-15K in Genmab - ADR, made on February 10, 2025.

Members of Congress or their families often buy or sell securities and have access to non-public information through their roles. The STOCK Act requires them to report these trades within 45 days to ensure transparency and reduce conflicts of interest.